| ABIRATERONE |
Zytiga® |
Janssen-Cilag Pty Ltd |
|
Mar 2012 |
|
| AFLIBERCEPT |
Eylea® |
Bayer Australia Ltd |
|
Mar 2012 |
|
| AGOMELATINE |
Valdoxan® |
Servier Laboratories (Aust.) Pty. Ltd. |
|
Mar 2012 |
|
| BOCEPREVIR |
Victrelis® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2012 |
|
| BORTEZOMIB |
Velcade® |
Janssen-Cilag Pty Ltd |
|
Mar 2012 |
|
| DAPAGLIFLOZIN |
Forxiga® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2012 |
|
| DAPAGLIFLOZIN |
Forxiga® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2012 |
|
| DENOSUMAB |
Prolia® |
Amgen Australia Pty Limited |
|
Mar 2012 |
|
| ETANERCEPT |
Enbrel® |
Pfizer Australia Pty Ltd |
|
Mar 2012 |
|
| EZETIMIBE WITH SIMVASTATIN |
Vytorin® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2012 |
|
| HUMAN MENOPAUSAL GONADOTROPHIN |
Menopur® |
Ferring Pharmaceuticals Pty Limited |
|
Mar 2012 |
|
| IMATINIB |
Glivec® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Mar 2012 |
|
| IPILIMUMAB |
Yervoy® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2012 |
|
| NAPROXEN AND ESOMEPRAZOLE |
Vimovo® |
AstraZeneca Pty Ltd |
|
Mar 2012 |
|
| PAZOPANIB |
Votrient® |
GlaxoSmithKline Australia Pty Ltd |
|
Mar 2012 |
|
| PREGABALIN |
Lyrica® |
Pfizer Australia Pty Ltd |
|
Mar 2012 |
|
| RASAGILINE |
Azilect® |
Lundbeck Australia Pty Ltd |
|
Mar 2012 |
|
| RIVAROXABAN |
Xarelto® |
Bayer Australia Ltd |
|
Mar 2012 |
|
| RIVAROXABAN (AF) |
Xarelto® |
Bayer Australia Ltd |
|
Mar 2012 |
|
| SUNITINIB MALATE |
Sutent® |
Pfizer Australia Pty Ltd |
|
Mar 2012 |
|
| TAFLUPROST |
Saflutan® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2012 |
|
| TALIGLUCERASE ALFA |
Elelyso® |
Pfizer Australia Pty Ltd |
|
Mar 2012 |
|
| TAPENTADOL |
Palexia SR® |
CSL Limited |
|
Mar 2012 |
|
| TELAPREVIR |
Incivo® |
Janssen-Cilag Pty Ltd |
|
Mar 2012 |
|
| VELAGLUCERASE ALFA |
VPRIV® |
Shire Australia Pty Ltd |
|
Mar 2012 |
|